New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

about

What's in a Name? Classification of Diabetes Mellitus in Veterinary Medicine and Why It Matters.Dipeptidyl peptidase-4 inhibitors and cancer risk in patients with type 2 diabetes: a meta-analysis of randomized clinical trials.Role of Disulfide Bonds in Activity and Stability of Tigerinin-1R.

P2860

Q37412811-7F90B497-D9B7-42E4-84F3-3FD84B09ADD4 Q41422603-64134DC5-5A30-4C22-82B2-480C936E105F Q48184907-28A285C5-C23E-44AE-9A7A-B238CD17E92E

P2860

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

Item

http://www.wikidata.org/entity/Q38937626

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

@en

type

Item

label

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

@en

prefLabel

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

@en

P1476

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs

@en

P2093

Chen Gilor

http://www.w3.org/2001/XMLSchema#string

Melanie J Hall

http://www.w3.org/2001/XMLSchema#string

P2860

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1

Nutrient-dependent secretion of glucose-dependent insulinotropic polypeptide from primary murine K cells

Bariatric Surgery for Type 2 Diabetes Mellitus in Patients with BMI <30 kg/m2: A Systematic Review and Meta-Analysis

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

Biology of incretins: GLP-1 and GIP

Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: an interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled tr

Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function?

Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human islets.

Novel glucagon-like peptide-1 analog delivered orally reduces postprandial glucose excursions in porcine and canine models.

P304

733-743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1098612X16660441

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A J Rudinsky

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27562982

http://www.w3.org/2001/XMLSchema#string

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

about

P2860

P2860

New Approaches to Feline Diabetes Mellitus: Glucagon-like peptide-1 analogs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698